Gene · 6304
Papers1,882
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,882
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential key genes and molecular mechanisms of oral squamous cell carcinoma based on integrated bioinformatics approach. | J Genet Eng Biotechnol | 2026 | 41839689 | PubTator, text mining | PubMed |
| IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cells. | Sci Adv | 2026 | 41824575 | PubTator, text mining | PubMed |
| Retraction: Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease Progression. | PLoS One | 2026 | 41818178 | PubTator, text mining | PubMed |
| Histone deacetylases: Function in tumor development and therapeutic prospects (Review). | Oncol Lett | 2026 | 41783166 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide association study and meta-analysis of lung function decline. | Respir Res | 2026 | 41764487 | PubTator, text mining | PubMed |
| Higher Purity of Phosphatidylserine Improves Human Cortical Neuron Function by Modulating SIRT1-PGC-1α Pathways. | Brain Sci | 2026 | 41750195 | PubTator, text mining | PubMed |
| From Bench to Bedside: Advancements in Precision Oncology and Drug Discovery for Osteosarcoma. | Cancers (Basel) | 2026 | 41749815 | PubTator, text mining | PubMed |
| Interleukin-23p19 Inhibitors in Inflammatory Bowel Disease: From Current Insights to Future Directions. | J Pers Med | 2026 | 41745409 | PubTator, text mining | PubMed |
| Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis. | Drug Des Devel Ther | 2026 | 41728357 | PubTator, text mining | PubMed |
| Proteome-Wide Analysis of Functional Phosphosites in the FGFR Family of Proteins: Insights from Large-Scale Phosphoproteomic Analysis. | Proteomes | 2026 | 41718090 | PubTator, text mining | PubMed |
| Correction: LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis. | Cell Death Dis | 2026 | 41605907 | PubTator, text mining | PubMed |
| Integrative epigenetics and transcriptomics identify aging genes in human blood. | Nat Commun | 2026 | 41554691 | PubTator, text mining | PubMed |
| Association of NLRC3 gene polymorphism with Graves' disease susceptibility in a Southwest Chinese Han population. | Hum Immunol | 2026 | 41547091 | PubTator, text mining | PubMed |
| Investigating causal relations between brain morphology and genetic risk variants in Parkinson's disease. | Neuroimage Clin | 2026 | 41519071 | PubTator, text mining | PubMed |
| A novel peptide antagonist for SATB1 in the immune response to Leishmania infection. | Microb Pathog | 2026 | 41275936 | PubTator, text mining | PubMed |
| SATB1 regulates TXNIP inhibiting invasion and infiltration in T-cell acute lymphoblastic leukemia. | Cancer Gene Ther | 2026 | 41125904 | PubTator, text mining | PubMed |
| Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis. | bioRxiv | 2025 | 41783369 | PubTator, text mining | PubMed |
| In Vitro retinal ganglion cell differentiation and enrichment under the scope: do subtypes matter? | Front Cell Dev Biol | 2025 | 41777802 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| Enhanced anti-liver tumor efficacy of chimeric antigen receptor-T cells via SATB1 modulation. | Cell Death Dis | 2025 | 41372119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6304/papers?page=2